Skip to content

IV Fluids and Post-ERCP Pancreatitis

ERCP

Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impractical. To date, no studies have prospectively assessed short-term (60-90 minute) aggressive hydration regimens that are feasible for outpatients undergoing ERCP and subsequent discharge. Furthermore, little is known with regard to fluid type, volume, and timing with respect to ERCP. In this study, we will aim to assess whether the amount of peri-procedural intravenous fluid administered around the time of ERCP is associated with the risk of PEP (the primary outcome).

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Subject referred for ERCP, regardless of indication;
* Subject age 18 years or older;
* Subject able to give informed consent to involvement be included.

Exclusion Criteria:

* Subject has a standard contraindication to ERCP;
* Subject or surrogate unable or unwilling to provide informed consent;
* Subject age \< 18 years.

Lieu de l'étude

Peter Lougheed Hospital
Peter Lougheed Hospital
Calgary, Alberta
Canada

Contactez l'équipe d'étude

Primary Contact

Nauzer Forbes, MD MSc

[email protected]
403-592-5089
Étude parrainée par
University of Calgary
Participants recherchés
Plus d'informations
ID de l'étude: NCT05211206